Maintenance of intestinal homeostasis by mucosal barriers.
Okumura R, Takeda K. · 2018
Read Maintenance of intestinal homeostasis by mucosal barriers. by Okumura R, Takeda K. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5879757.txt.
Introduction
Okumura and Takeda review how mucosal barriers keep the gut in balance. Their article appeared in Inflammation and Regeneration. Trillions of microbes live in the human intestine. They aid nutrition, metabolism, and immunity. A barrier of gut lining cells keeps them at a safe distance. The review explains how that barrier holds homeostasis. It sorts barriers into chemical and physical kinds.
Chemical barriers include antimicrobial peptides that attack invaders. Physical barriers include mucus and tight cell junctions. Microbes and immune cells tune both layers with care. When the barrier fails, bacteria breach the gut wall. Excess immune response and inflammation can follow. Such failure feeds inflammatory bowel disease, they note.
Catalog record
| CREATOR | Okumura R, Takeda K. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Maintenance of intestinal homeostasis by mucosal barriers By Ryu Okumura, Kiyoshi Takeda Published in: Inflammation and Regeneration DOI: 10.1186/s41232-018-0063-z ABSTRACT Background The intestine is inhabited by a tremendous number of microorganisms, which provide many benefits to nutrition, metabolism and immunity. Mucosal barriers by intestinal epithelial cells make it possible to maintain the symbiotic relationship between the gut microbiota and the host by separating them. Recent evidence indicates that mucosal barrier dysfunction contributes to the development of inflammatory bowel disease (IBD). In this review, we focus on the mechanisms by which mucosal barriers maintain gut homeostasis. Main text Gut mucosal barriers are classified into chemical and physical barriers. Chemical barriers, including antimicrobial peptides (AMPs), are chemical agents that attack invading microorganisms, and physical barriers, including the mucus layer and the cell junction, are walls that physically repel invading microorganisms. These barriers, which are ingeniously modulated by gut microbiota and host immune cells, spatially segregate gut microbiota and the host immunity to avoid unnecessary immune responses to gut commensal microbes. Therefore, mucosal barrier dysfunction allows gut bacteria to invade gut mucosa, inducing excessive immune responses of the host immune cells, which result in intestinal inflammation. Conclusion Gut mucosal barriers constructed by intestinal epithelial cells maintain gut homeostasis by segregating gut microbiota and host immune cells. Impaired mucosal barrier function contributes to the development of IBD. However, the mechanism by which the mucosal barrier is regulated by gut microbiota remains unclear. Thus, it should be further elucidated in the future to develop a novel therapeutic approach to IBD by targeting the mucosal barrier. BACKGROUND The mammalian intestine is a special place for microorganisms, where a high abundance of nutrients derived from foods are present and an aerobic condition is maintained. Therefore, tremendous numbers of microorganisms mainly composed of aerobic bacteria grow and inhabit the intestine. The intestinal microorganisms including bacteria, fungi and viruses form an ecological community termed the gut microbiota, which does not only reside in the gut but also provide many benefits to nutrition, metabolism and immunity. Short-chain fatty acid (SCFA), which is a gut microbial metabolite produced from dietary fibers, is used as an energy source of the host. In addition, SCFA contributes to the modulation of mucosal immunity by enhancing mucus production and promoting regulatory T cell (Treg) development [1–3]. Moreover, gut bacteria synthesize several kinds of vitamins including vitamin B and vitamin K, which are critical for sugar and fat metabolism and maintenance of hemostatic function. Thus, gut microbiota forms a win-win relationship with the host. However, mammalian immune cells such as macrophages and neutrophils are programmed to attack invading extraneous organisms. Gut microbes are no exception and can be targeted by host immune cells. Accordingly, there is a barrier system—mucosal barrier—for separating gut microbiota and the host immunity to avoid an unfavorable interaction between the two. Mucosal barrier impairment allows gut microbes to easily enter the mucosa, which induce intestinal inflammation as a consequence of the host’s excessive immune responses to gut microbes. Inflammatory bowel diseases (IBD) such as Crohn’s disease (CD) and ulcerative colitis (UC) involve choric intestinal inflammation in humans. Recent evidence based on the combination of the human genome-wide association study (GWAS) and genetically modified mouse studies have revealed that intestinal barrier dysfunction is one cause of IBD [4]. In addition, reduced production of mucosal barrier components such as mucus and antimicrobial peptides is observed in the intestine of some IBD patients. These findings indicate that the mucosal barrier is indispensable for maintaining the gut environment and preventing intestinal inflammation. In this review, we discuss the mechanisms of the gut mucosal barrier constructed by IECs and the regulation of intestinal inflammation by the mucosal barrier. Mucosal barriers formed by intestinal epithelial cells IECs at the surface of the gut mucosa absorb nutrients and water from ingested foods. They also play important roles in generating various types of barriers to protect mucosa from commensal microbes and invading pathogenic microorganisms (Fig. 1). These barriers have two subtypes, chemical and physical barriers.Fig. 1Mucosal barriers in the gut. Chemical barriers including AMPs and Reg3γ secreted by Paneth cells mainly contribute to the separation between intestinal bacteria and IECs in the small intestine. By contrast, in the large intestine where a tremendous number of bacteria exist, intestinal bacteria and IECs are largely segregated by physical barriers such as the inner mucus layer composed of polymerized MUC2 mucin. Lypd8, a highly glycosylated GPI-anchored protein expressed on IECs, inhibits the bacterial invasion of the inner mucus layer by binding to intestinal bacteria, especially flagellated bacteria. AMP: antimicrobial peptide Chemical barrier Chemical barriers consist of antimicrobial peptides (AMPs), the regenerating islet-derived 3 (Reg3) family of proteins, lysozyme and secretory phospholipase A2. All of these are mainly involved in the segregation of gut bacteria and IECs in the small intestine [5, 6]. Paneth cells play a crucial role in the mucosal barrier of the small intestine by producing a large number of antimicrobials [7]. AMPs are basic amino acid-rich cationic small proteins, which are evolutionally conserved in a wide range of organisms. They include the defensin family of proteins and cathelicidins, both of which bind to the negatively charged microbial cell membrane and induce disruption of membrane integrity by forming a pore-like structure [8]. Defensin family proteins are classified into α-, β- and θ-defensins, among which α-defensin (also referred to as cryptdins in mice) is most highly expressed in Paneth cells and mainly protects against infection by Gram-positive and Gram-negative bacteria. Pro-cryptdin is converted into mature-cryptdin by matrix metalloproteinase-7 (MMP-7) in mice. Therefore, MMP-7-deficient mice lack mature-cryptdin, resulting in high susceptibility to Salmonella typhimurium infection [9]. Moreover, mature α-defensin deficiency is associated with alteration of the gut microbiota: a decrease of Bacteroidetes and an increase in Firmicutes [10]. These results demonstrate that AMPs largely contribute to the homeostatic state of the gut environment by regulating pathogenic bacteria [11]. The Reg3 family proteins are C-type lectins, which exert an antibacterial effect on Gram-positive bacteria by binding to the bacterial membrane and forming a hexameric membrane-permeabilizing oligomeric pore [12]. In mice lacking Reg3γ, increased bacterial colonization on the epithelial surface of the small intestine was observed, indicating that Reg3γ is indispensable to the spatial separation of the intestinal bacteria and intestinal epithelia of the small intestine [6, 12, 13]. Physical barriers Chemical barriers are major players in the segregation of gut microbiota and the small intestinal epithelia. However, in the large intestine, where there is nothing resembling Paneth cells that secrete antimicrobials, physical barriers mainly contribute to spatial segregation of gut microbiota and intestinal epithelia. Physical barriers consist of the mucus layer covering the intestinal mucosa, the glycocalyx on the microvilli of absorptive IECs, and the cell junctions firmly linking IECs. These barriers physically inhibit the microbial invasion of the mucosa. Mucus is a viscous fluid secreted by goblet cells. It is enriched in mucin glycoproteins that form large net-like polymers [14]. In the large intestine, where tremendous numbers of intestinal bacteria exist compared with the small intestine, the number of goblet cells is much higher and the large intestinal epithelia are covered by a thick two-layered mucus layer: the outer loose and the inner firm mucus layer [15]. These two mucus layers are constructed